Department of Chemistry, University of Rome Tor Vergata, Via della Ricerca Scientifica, 00133, Rome, Italy.
Ulisse BioMed S.r.l., Area Science Park, 34149, Trieste, Italy.
Angew Chem Int Ed Engl. 2020 Aug 24;59(35):14973-14978. doi: 10.1002/anie.202005124. Epub 2020 Jun 9.
Easy-to-use platforms for rapid antibody detection are likely to improve molecular diagnostics and immunotherapy monitoring. However, current technologies require multi-step, time-consuming procedures that limit their applicability in these fields. Herein, we demonstrate effective molarity-driven electrochemical DNA-based detection of target antibodies. We show a highly selective, signal-on DNA-based sensor that takes advantage of antibody-binding-induced increase of local concentration to detect clinically relevant antibodies in blood serum. The sensing platform is modular, rapid, and versatile and allows the detection of both IgG and IgE antibodies. We also demonstrate the possible use of this strategy for the monitoring of therapeutic monoclonal antibodies in body fluids. Our approach highlights the potential of harnessing effective molarity for the design of electrochemical sensing strategies.
易于使用的快速抗体检测平台可能会改善分子诊断和免疫疗法监测。然而,目前的技术需要多步骤、耗时的程序,限制了它们在这些领域的适用性。在此,我们展示了基于有效摩尔浓度的电化学 DNA 靶向抗体检测。我们展示了一种高度选择性的、基于信号开启的 DNA 传感器,它利用抗体结合诱导的局部浓度增加来检测血清中与临床相关的抗体。该传感平台具有模块化、快速和多功能的特点,允许同时检测 IgG 和 IgE 抗体。我们还证明了该策略在监测体液中治疗性单克隆抗体方面的应用潜力。我们的方法强调了利用有效摩尔浓度设计电化学传感策略的潜力。